Published in Acta Univ Palacki Olomuc Fac Med on January 01, 1981
Antibiotic treatment in preterm premature rupture of membranes and neonatal morbidity: a metaanalysis. Am J Obstet Gynecol (1996) 2.36
Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer. Cancer Res (1990) 2.09
Falloposcopic instillation of prostaglandin in tubal pregnancy. Lancet (1993) 1.92
Mode of delivery is associated with maternal and fetal endocrine stress response. BJOG (2006) 1.81
Is the formation of a bladder flap at cesarean necessary? A randomized trial. Obstet Gynecol (2001) 1.56
Successful treatment of a heterotopic pregnancy by sonographically guided instillation of hyperosmolar glucose. Fertil Steril (1998) 1.54
Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: a randomized, double-blind, placebo-controlled trial. Clin Pharmacol Ther (1999) 1.50
Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol (1984) 1.49
High prevalence of hyperhomocysteinemia in critically ill patients. Crit Care Med (2000) 1.46
[Contraceptive efficiency of triphasic inhibitors (author's transl)]. Med Klin (1977) 1.44
Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on. Lancet (1990) 1.41
Epinephrine application via an endotracheal airway and via the Combitube in esophageal position. Crit Care Med (2000) 1.41
[Adjuvant hormonal therapy in lymph node-negative breast carcinoma patients in the postmenopause]. Dtsch Med Wochenschr (1992) 1.39
First successful intrauterine pregnancy after treatment of tubal pregnancy with prostaglandin F2 alpha. Am J Obstet Gynecol (1989) 1.38
Membranes of glyoxysomes from castor-bean endosperm. Enzymes bound to purified-membrane preparations. Eur J Biochem (1973) 1.35
Early postoperative stress: video-assisted wedge resection/lobectomy vs conventional axillary thoracotomy. Chest (1996) 1.24
Characterization of a vitamin D receptor knockout mouse as a model of colorectal hyperproliferation and DNA damage. Carcinogenesis (2001) 1.20
Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science (1982) 1.20
Perinatal mortality and morbidity. Comparison between maternal transport, neonatal transport and inpatient antenatal treatment. Arch Gynecol Obstet (2001) 1.15
A reactive aspartyl residue of pepsin. Biochem Biophys Res Commun (1968) 1.13
Influence of acupuncture on maternal serum levels of interleukin-8, prostaglandin F2alpha, and beta-endorphin: a matched pair study. Obstet Gynecol (1998) 1.12
CA 125 as an independent prognostic factor for survival in patients with epithelial ovarian cancer. Am J Obstet Gynecol (1989) 1.10
A CA125 score as a prognostic index in patients with ovarian cancer. Arch Gynecol Obstet (1990) 1.09
Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors. Ann Surg (1993) 1.09
Transcapillary insulin transfer in human skeletal muscle. Eur J Clin Invest (2003) 1.08
Prostaglandin versus expectant management in early tubal pregnancy. Prostaglandins Leukot Essent Fatty Acids (1991) 1.08
Three-dimensional video-endoscopy: clinical use in gynaecological laparoscopy. Lancet (1994) 1.07
Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab (1997) 1.07
Increased plasma leptin in gestational diabetes. Diabetologia (2001) 1.06
Acupuncture for cervical ripening and induction of labor at term--a randomized controlled trial. Wien Klin Wochenschr (2001) 1.03
Serum placental lactogen (HPL) as index of placental function. Acta Endocrinol (Copenh) (1971) 1.02
Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Endocr Relat Cancer (2008) 1.01
A meta-analysis of low dose aspirin for the prevention of intrauterine growth retardation. Br J Obstet Gynaecol (1997) 1.00
Human cervical ripening is associated with an increase in cervical inducible nitric oxide synthase expression. Biol Reprod (1999) 0.99
Hormone studies in females with androgenic hairloss. Gynecol Obstet Invest (1991) 0.99
Prognostic significance of immunohistochemical parameters in breast carcinomas. Pathol Res Pract (1988) 0.96
Ultrastructural and immunohistochemical characteristics of lipid-rich carcinoma of the breast. Virchows Arch A Pathol Anat Histopathol (1988) 0.96
Simultaneous and sequential determinations of steroid hormone receptors in human breast cancer. Influence of intervening therapy. Ann Surg (1985) 0.94
Agnus castus extracts inhibit prolactin secretion of rat pituitary cells. Horm Metab Res (1993) 0.94
[Treatment of mastopathy with cyclic mastodynia: clinical results and hormone profile]. Gynakol Rundsch (1986) 0.94
TNFalpha-mediated induction of PAI-1 restricts invasion of HTR-8/SVneo trophoblast cells. Placenta (2005) 0.94
Protein composition of the glyoxysomal membrane. FEBS Lett (1974) 0.94
Androgen receptors, serum androgen levels and survival of breast cancer patients. Arch Gynecol Obstet (1990) 0.93
Ectopic pregnancy. Arch Gynecol Obstet (2000) 0.93
[Hemodialysis and labor]. Zentralbl Gynakol (1968) 0.91
Cervical length and dilatation of the internal cervical os detected by vaginal ultrasonography as markers for preterm delivery: A systematic review. Am J Obstet Gynecol (1999) 0.91
The inactivation of pepsin by an equimolar amount of 1-diazo-4-phenylbutanone-2. Biochem Biophys Res Commun (1967) 0.91
Tamoxifen in refractory ovarian cancer: the use of a loading dose schedule. Br J Cancer (1988) 0.91
Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertil Steril (1999) 0.90
Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother (1988) 0.90
Correlation between serum testosterone levels and peripartal mood states. Acta Obstet Gynecol Scand (2001) 0.89
Risk factors for third-degree perineal tears in vaginal delivery, with an analysis of episiotomy types. J Reprod Med (2001) 0.89
Production of pro- and anti-inflammatory cytokines of human placental trophoblasts in response to pathogenic bacteria. J Soc Gynecol Investig (2001) 0.89
Tissue-specific and ubiquitous basic helix-loop-helix transcription factors in human placental trophoblasts. Placenta (2005) 0.89
Is induction of labor indicated in prolonged pregnancy? Results of a prospective randomised trial. Gynecol Obstet Invest (1989) 0.89
Impaired production of tumor necrosis factor in breast cancer. Cancer (1990) 0.89
Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol (1999) 0.88
[Clinical significance of the tumor marker CA-125 for the preoperative diagnosis and postoperative management of patients with malignant ovarian cancers]. Geburtshilfe Frauenheilkd (1985) 0.88
HLA-antigen distribution in seminoma, HCG-positive seminoma and non-seminomatous tumours of the testis. Urol Res (1989) 0.88
Plasma levels of oxytocin and 13, 14-dihydro-15-keto prostaglandin F2 alpha in preterm labor and the effect of ethanol and ritodrine. Am J Obstet Gynecol (1982) 0.88
TNF-alpha/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta (2000) 0.88
Molecular cloning of the human Hand1 gene/cDNA and its tissue-restricted expression in cytotrophoblastic cells and heart. Gene (1998) 0.88
[Management of postpartum hemorrhage (PPH): algorithm of the interdisciplinary D-A-CH consensus group PPH (Germany - Austria - Switzerland)]. Anaesthesist (2014) 0.88
Early diagnosis and curative therapy of medullary thyroid carcinoma by routine measurement of serum calcitonin in patients with thyroid disorders. Thyroid (2005) 0.88
Plasminogen activators, plasminogen activator inhibitor, and fibronectin in human granulosa cells and follicular fluid related to oocyte maturation and intrafollicular gonadotropin levels. Fertil Steril (1990) 0.87
Impact of maternal body build characteristics on newborn size in two different European populations. Hum Biol (1998) 0.87
Cystic fibrosis screening in neonates--measurement of immunoreactive trypsin and direct genotype analysis for delta F508 mutation. Eur J Pediatr (1994) 0.87
Frequency of RET proto-oncogene mutations in patients with normal and with moderately elevated pentagastrin-stimulated serum concentrations of calcitonin. Thyroid (2004) 0.87
Relationship between the steroid and prolactin concentration in follicular fluid and the maturation and fertilization of human oocytes. J In Vitro Fert Embryo Transf (1987) 0.86
The role of oxytocin in relation to female sexual arousal. Gynecol Obstet Invest (1999) 0.86
Treatment of skin ageing symptoms in perimenopausal females with estrogen compounds. A pilot study. Maturitas (1994) 0.86
Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol. Fertil Steril (1993) 0.86
Chromosome abnormalities in 150 couples with multiple spontaneous abortions. Fertil Steril (1982) 0.86
Influence of acupuncture on duration of labor. Gynecol Obstet Invest (1998) 0.86
Measurement of eicosanoids in menstrual fluid by the combined use of high pressure chromatography and radioimmunoassay. Prostaglandins (1993) 0.86
Histopathologic characterization of human breast cancer in correlation with estrogen receptor status. A comparison of immunocytochemical and biochemical analysis. Cancer (1988) 0.85
Oxytocin and the initiation of human parturition. II. Stimulation of prostaglandin production in human decidua by oxytocin. Am J Obstet Gynecol (1981) 0.85
Adjunctive antibiotic treatment in preterm labor and neonatal morbidity: a meta-analysis. Obstet Gynecol (1996) 0.85
Estrogen receptor analysis on biopsies and fine-needle aspirates from human breast carcinoma. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Am J Pathol (1986) 0.85
Oestrogen and progesterone receptor content as a prognostic factor in advanced epithelial ovarian carcinoma. Br J Obstet Gynaecol (1990) 0.85
Determination of HER-2/neu amplification and expression in tumor tissue and cultured cells using a simple, phenol free method for nucleic acid isolation. Oncogene (1990) 0.85
MDR1 gene expression and prognostic factors in primary breast carcinomas. Eur J Cancer (1991) 0.85
Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin. Thyroid (2000) 0.85
Is CA-125 monitoring useful in patients with epithelial ovarian carcinoma and preoperative negative CA-125 serum levels? Gynecol Oncol (1991) 0.84
Oxytocin and the initiation of human parturition. I. Prostaglandin release during induction of labor by oxytocin. Am J Obstet Gynecol (1981) 0.84
[Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women]. Hautarzt (1991) 0.84
Treatment of skin aging with topical estrogens. Int J Dermatol (1996) 0.84
[Oestrogen receptors and prognosis in breast cancer]. Wien Klin Wochenschr (1980) 0.84
Promoter elements and transcription factors involved in differentiation-dependent human chorionic gonadotrophin-alpha messenger ribonucleic acid expression of term villous trophoblasts. Endocrinology (2000) 0.84
Laminin in pregnancy. Gynecol Obstet Invest (1986) 0.84
Cytokine and prostaglandin production by amnion cells in response to the addition of different bacteria. Am J Obstet Gynecol (1998) 0.84
Biochemistry of myometrial contractility. Baillieres Clin Obstet Gynaecol (1992) 0.84
Hormone serum levels during oral cimetidine treatment of patients with peptic ulcers. Hepatogastroenterology (1981) 0.84
Effect of cervical application of prostaglandin (PG) E2 on plasma 13,14-dihydro-15-keto-PGF2 alpha and oxytocin in pregnant women at term. Br J Obstet Gynaecol (1983) 0.83
[Treatment of tubal pregnancy by local and systemic administration of prostaglandin. Initial experiences]. Geburtshilfe Frauenheilkd (1988) 0.83
Hormone serum levels and hormone receptor contents of endometria in women with normal menstrual cycles and patients bearing endometrial carcinoma. Gynecol Obstet Invest (1979) 0.83